Based on the previous experiments with the N17 mutant of CDC42, it has been speculated, but not proved as yet, that CDC42 is required for Ras-induced malignant transformation of ®broblasts. However, since this inhibitor could sequester many GDP-dissociation stimulators (GDSs), such as DBL, OST and Tiam-1 which activate not only CDC42, but also Rho or Rac, in fact it is not a speci®c inhibitor that inactivates only CDC42. Thus, we have taken the minimum CDC42-binding domain (residues 504 ± 545, called ACK42) of the Tyrkinase ACK-1 that binds only CDC42 in the GTP-bound form, and thereby blocking the interactions of CDC42-GTP with its downstream eectors such as ACKs, PAKs and N-WASP. First of all, using the ACK42-GST fusion protein as a speci®c ligand for the GTP-CDC42 complex, we have revealed that CDC42 is activated by oncogenic Ras mutants such as v-Ha-Ras in NIH3T3 ®broblasts, and similarly in PC12 cells by both NGF (Nerve Growth Factor) and EGF (Epidermal Growth Factor) which activate the endogenous normal Ras, providing the ®rst direct evidence that CDC42 acts downstream of Ras and NGF/EGF. Furthermore, overexpression of ACK42 completely reversed Ras-induced malignant phenotypes such as focus formation and anchorage/serum-independent growth of the ®broblasts, and a cell-permeable derivative of ACK42 called WR-ACK42 strongly inhibited the growth of Ras transformants, with little eect on the parental normal cell growth, and also abolished Ras-induced ®lopodium/ microspike formation of the ®broblasts which is CDC42-dependent. These observations unambiguously proved for the ®rst time that the RAS-induced activation of CDC42 is indeed essential for Ras to transform the ®broblasts, and furthermore suggest that ACK42 or its peptidomimetics are potentially useful for genotherapy or chemotherapy of Ras-associated cancer.
Introduction
Rho family GTPases including Rho, Rac and CDC42 play the major role in controlling actin cytoskeleton organization (Hall, 1998) . Rho is required for the formation of stress ®bers, focal adhesion plaques and contractile ring. Rac is essential for membrane ruing. CDC42 is required for microspike/®lopodium formation. Ras is involved in the activation of some of these Rho family GTPases. For instance, Rac is activated by a Rac GDP-dissociation stimulator (GDS) called Vav that is activated by the Tyr-kinase Lck and an endproduct of PI-3 kinase (Crespo et al., 1997; Han et al., 1998) , the latter kinase being activated by Ras (Rodriguez-Viciana et al., 1997) . CDC42 is activated through bradykinin B2 receptor (BB2R), and the BB2R gene is activated by Ras through an as yet uncharacterized pathway (Kozma et al., 1995; Downward et al., 1988) . These ®ndings together lead us to a speculation that Ras is involved in the activation of CDC42. Interestingly, the N17 mutant of CDC42 inhibits both Ras/Raf-induced focus formation of normal ®broblasts (Qui et al., 1997) , suggesting that (i) CDC42 might be essential for both Ras/Raftransformation, and that (ii) Raf might be involved in Ras-induced activation of CDC42.
However, strictly speaking, the N17 mutant of CDC42 blocks not only the activation of CDC42 by sequestering a CDC42-speci®c GDP-dissociation stimulator (GDS) called FGD1, but also could block at least in part the activation of other Rho family G proteins such as Rac and Rho by sequestering DBL, OST and Tiam-1, GDSs that activate Rho or Rac, in addition to CDC42 (Maruta, 1998; Feig, 1999) . Thus, it still remains to be clari®ed whether the observed eect of the N17 mutant of CDC42 is due solely to the inactivation of CDC42, or also to the inactivation of both Rac and Rho. The N17 mutant of Rac also inhibits Ras-induced malignant transformation (Qui et al., 1995) . Rho GTPases, in particular RhoB, also appear to be essential for Ras transformation, as a farnesyltransferase inhibitor that blocks the farnesylation of Rho B reverses Ras transformation (Lebowitz et al., 1995) , and the bacterial exotoxin C3 that speci®cally inactivates Rho GTPases by ADP ribosylation selectively inhibits the growth of Ras transformants, but not the parental normal ®broblasts (He et al., manuscript in preparation). It has recently been suggested that Rho is activated by Ras through the SH3 domain of a Ras GAP of 120 kDa (Leblanc et al., 1998) . Thus, to determine unambiguously whether CDC42 is essential for Ras transformation, it is critical to create a new inhibitor which is highlyspeci®c for CDC42, and has no eect on any other related GTPases. Interestingly, the Tyr-kinases ACK-1 and ACK-2 bind only CDC42 in the GTP-bound form (Manser et al., 1993; Yang and Cerione, 1997) .
In this study, using ACK42 which is the minimum CDC42-binding fragment of ACK-1 (residues 504 ± 545) (Mott et al., 1999) , we provide the direct evidence for the Ras-induced activation of CDC42. Furthermore, by either the conventional DNA transfection or a novel delivery through a cell-permeable peptide vector of 16 amino acids called penetratin or WR (Derossi et al., 1998) , we demonstrate that v-Ha-Rasinduced malignant transformation and is completely suppressed by this truly CDC42-speci®c inhibitor, ACK42, clearly proving for the ®rst time that CDC42 is essential for Ras transformation. Our ®ndings indicate that the ACK42-WR conjugate is the ®rst cell-permeable tool for blocking selectively the CDC42-dependent signaling pathways of the intact cells, and suggest that ACK42 mimetics are potentially useful for the treatment of Ras-associated cancers.
Results

Ras and NGF induce the activation of CDC42
Like full-length ACK-1 and ACK-2, ACK42 binds only the CDC42-GTP complex, and not any other GTPases (E Manser, personal communication) . Thus, to monitor whether Ras transformation causes any activatiaon of CDC42 (conversion from the GDPbound form to the GTP-bound form), we have used ACK42-GST fusion protein as a speci®c ligand for the active GTP-CDC42 complex. We found that ACK42-GST beads bind much more CDC42 in the lysate from Ras transformed than the parental normal NIH3T3 cells, although the total levels of CDC42 are not changed by Ras transformation (see Figure 1a) , clearly indicating that Ras induces the activation of CDC42. Similarly, NGF which induces the activation of Ras also induces the activation of CDC42 in PC12 cells (see Figure 1b ).
Over-expression of ACK42 suppresses v-Ha-Ras-induced transformation of NIH3T3 cells
To determine unambiguously whether CDC42 is essential for Ras transformation, we have overexpressed ACK42, the CDC42-speci®c inhibitor, in vHa-Ras-transformed NIH3T3 cells. ACK42 selectively blocks the interactions of CDC42 with any of its eectors including ACK family kinases, PAK family kinases and N-WASP. Approximately 30 neomycin resistant transfectants were selected at random, and their morphology was analysed (see Figure 2) . Like normal NIH3T3 ®broblasts, the ACK42 transfectants formed a thin monolayer in a liquid culture, and no longer formed foci by piling up on top of each other, indicating that contact inhibition of growth is restored in these transfectants.
Changes in growth behavior of v-Ha-Ras transformed cells by blocking CDC42 signals
Unlike the parental v-Ha-Ras transformants which grow in soft agar in an anchorage-independent manner, the ACK42 over-expressors are no longer able to grow in soft agar (see Table 1 ), clearly indicating that CDC42 is required for the anchorage-independent growth. The saturation density and contact inhibition of the ACK42 over-expressors were compared with those of parental v-Ha-Ras transformants. The ACK42 over-expressors stop growing at much lower density of cells, compared with the parental v-Ha-Ras transformants (see Figure 3a) . Furthermore, the parental v-HaRas transformants grew at much lower serum concentrations, compared with the ACK42 overexpressors which require much higher serum concentrations as do normal ®broblasts (Figure 3b ). Northern blot analysis con®rmed that all ACK42 transfectants (v-Ras) and one of the typical ACK42 transfectants (MAK4) were grown to near con¯uency. Unlike the transformants, the ACK42 transfectants no longer formed a focus, and showed a¯at morphology express ACK42 mRNA (Figure 4a ). Furthermore, vHa-Ras protein levels in the parental, pMV7 transfected and ACK42 over-expressing cells were quite similar (Figure 4b ), con®rming that ACK42 does not aect v-Ha-Ras expression levels. These observations clearly indicate that over-expression of ACK42 suppresses v-Ha-Ras-induced malignant transformation, and con®rm that CDC42 is indeed required for Ras-induced malignant phenotypes including the anchorage-dependent growth, loss of contact inhibition and serum-independency for growth.
The cell-permeable ACK42 derivative blocks the growth of Ras transformants and ®lopodium formation
To deliver a variety of`cargo' peptides of less than 100 amino acids such as ACK42 into the cytoplasm or nucleoplasm of target cells, a series of novel peptide vectors/vehicles of 16 amino acids called penetratins have been recently developed (for a review see Derossi et al., 1998) . Penetratins are potentially quite useful tools for comparing the anti-cancer potential of the given`cargo' peptide with its mutants quantitatively to screen for its higher-anity (and therefore more potent) mutants. The simplest version of penetratins, called WR, consists of only ten Arg residues and six Trp residues (Williams et al., 1997) . To determine a dose-response eect of the anti-Ras peptide ACK42 on the growth of Ras transformants, we ®rst generated in E. coli a recombinant thrombin-cleavable fusion protein called GST-HA-WR-ACK42 in which the HA, a hemagglutinin epitope/¯ag of 12 amino acids, is¯anked by GST (at the N-terminus) and WR-ACK42 (at the C-terminus), and then anity-puri®ed it on GSH-beads. Since GST is too large as a cargo for the WR-mediated penetration across the plasma membranes, GST was then separated from the HA-WR-ACK42 by thrombin-cleavage.
The resulting`free' HA-WR-ACK42 (and a trace amount of thrombin) at various concentrations was added to the culture of Ras transformants or the parental normal ®broblasts, and its eect was Data presented are representative of three independent experiments monitored for 48 h. The HA-WR-ACK42 is indeed cell-permeable as judged by a¯uorescent staining of the treated cells with an anti-HA polyclonal antibody (see Figure 5) . Furthermore, HA-WR-ACK42 significantly inhibits the growth of Ras transformants in a dose-dependent manner (see Table 2 ) and their ®lopodium/microspike formation (see Figure 6 ). Under the same conditions, HA-WR-ACK42 has no eect on the growth of the normal cells (data not shown). These observations indicate that the cellpermeable ACK42 is a very useful tool for selectively inhibiting the CDC42-mediated pathways, and suggest the anti-cancer drug potential of its peptidomimetics for the treatment of Ras-associated cancers.
Discussion
Here, using a speci®c peptide which binds only CDC42 in the GTP-bound form, we have clearly demonstrated that (i) Ras/NGF induces the activation of CDC42, and that (ii) CDC42 is required for Ras-induced malignant transformation. Using a similar ACK42-based approach, we have found that the NGF-induced neurite outgrowth (NOG) of PC12 cells also requires CDC42 (Nur-E-Kamal et al., submitted). The CDC42/ GTP complex binds several distinct proteins including CDC42 GAPs such as n-chimaerin and p190-A as well as its eectors such as the Tyr kinase family ACKs and the Ser/Thr kinase family PAKs. The next question is what is an eector(s) of CDC42 that is responsible for NOG or Ras transformation. One of the ubiquitous CDC42-binding proteins called N-WASP, which is an F-actin severing protein rich in brain, has been recently shown to be an eector of CDC42 which is essential for the microspike/®lopodium formation in ®broblasts (Miki et al., 1998) . More recently, a dominant negative mutant of N-WASP, which no longer binds actin but still binds CDC42, blocks NOG of PC12 cells, supporting the notion that N-WASP is essential for the NOG as well (Miki et al., personal communication) . These ®ndings suggest the possibility that N-WASP acts as an eector of CDC42 for Ras transformation of ®broblasts as well. We are currently examining this possibility more directly by overexpressing an anti-sense N-WASP RNA.
Our ®nding that over-expression of ACK42 suppresses Ras transformation suggests a new avenue to the development of anti-Ras cancer drugs based on ACK42: a conjugate of ACK42 with the cell-permeable peptide vector (`penetratin' or its derivative WR) could be used for the peptidotherapy of Ras-associated cancers. In fact we have shown that addition of the ACK42-WR conjugate to the culture medium is sucient to inhibit strongly the growth of Rastransformed cells, but not the parental normal ®broblasts. Thus, ACK42 mimetics, chemical compounds that functionally mimic ACK42, also it could be potentially useful for the cancer chemotherapy. Previously we have shown that the minimal Rasbinding fragment (Raf81, residues 51 ± 131) of the Ser/ Thr kinase c-Raf-1 suppresses Ras transformation (Fridman et al., 1994) , and furthermore, to potentiate its anti-Ras action, we have created a few mutants of Raf81 which have much higher anity for the Ras/ GTP complex by replacing Gln64, Val70, Ala85 or Val 88 with basic amino acids (Arg or Lys) (Maruta, 1996) . Similarly, by a PCR-based site-directed mutagenesis, we are currently screening for the mutants of ACK42 that show a much higher anity for the CDC42/GTP complex than the wild-type ACK42, to increase the anti-cancer therapeutic potential of ACK42.
We have found that at least two basic residues of ACK42, His17 and Arg/Lys 34, are absolutely essential (7) of HA-WR-ACK42 (2.5 mg/ml) were ®xed and stained with the¯uorescent anti-HA antibody to visualize the penetration of HA-WR-ACK42 into the cells as described under the`Materials and methods'. Both normal and Ras-transformed cells uptake HA-WR-ACK42 Table 2 Eect of a cell-permeable derivative of ACK42 on the growth of Ras transformants. Ras transformants were incubated in the presence of indicated concentrations of thrombin-cleaved GST-HA-WR-ACK42 (or GST or thrombin alone as controls) for 48 h, and cells were counted as described under the Materials and methods for the ACK-CDC42 interaction (Vuong Nheu et al., manuscript in preparation). Interestingly, His17 appears to bind Asp38 of CDC42 directly (Mott et al., 1999) . To identify the residue(s) in the switch II domain of CDC42 that binds Arg/Lys 34, we are currently determining the three-dimensional (3D) structure of ACK42 bound to the CDC42/GTP complex by X-ray crystallography (Rittinger et al., 1997) . Furthermore, based on the 3D structure of the highest-anity mutant of ACK42, we intend to design through a computer-based molecular modeling an ACK42 mimetic, the chemical compound that functionally mimics the ACK42 mutant. A similar approach could be taken with the as yet unidenti®ed minimal high-anity CDC42-binding fragment of N-WASP, PAKs or other CDC42/GTP-binding proteins.
We have shown that CDC42 acts downstream of Ras. How does Ras activate CDC42? Since Ras upregulates BB2R gene expression, we are currently determining whether BB2R antagonists such as Hoe 140 and FR173657 (Aramori et al., 1997) suppress Ras transformation, in order to explore the possible role of BB2R in Ras-mediated activation of CDC42.
Materials and methods
Monitoring the activation of CDC42 by ACK42-GST fusion protein
The ACK42 binds selectively CDC42 only in the active GTPbound form, and not in the inactive GDP-bound form (Manser et al., 1993; Mott et al., 1999) , as Raf 81/RBD (residues 51 ± 131) of c-Raf-1 binds the GTP-Ras, but not the GDP-Ras (Fridman et al., 1994; de Rooji and Bos, 1997) . Thus, the GTP-CDC42 levels in the Triton X-100 lysates derived from normal or v-Ha-Ras-transformed NIH3T3 cells and the control or NGF/EGF-treated PC12 cells were measured by using ACK42-GST beads as the activationspeci®c probe for CDC42, through the essentially same procedures previously described for monitoring the Ras activation (de Rooji and Bos, 1997) .
The following are the speci®c conditions used for this particular experiment: after overnight starvation of PC12 cells or normal NIH3T3 cells, they were incubated in the presence of either NGF or EGF (50 ng/ml) for 6 h, and these cells or v-Ha-Ras transformed NIH3T3 cells (5610 7 ) were then disrupted in the lysis buer containing 1% Triton X-100, 20 mM HEPES, pH 7.4, 150 mM NaCl, 10% glycerol, 1.5 mM MgCl 2 , 1 mM EGTA, 10 mM sodium pyrophosphate, 0.2 mM sodium 0-vanadate, 50 mM NaF, 0.5 mg/ml PMSF, and 0.5 mg/ml aprotinin. 500 mg protein of each cell lysate was mixed with 50 ml of ACK42-GST on GSH-beads, and incubated at 48C for 2 h. After washing the beads three times with the lysis buer, proteins bound to the beads were boiled in 50 ml of an SDS sample buer, and 15 ml of each sample was subjected to SDS ± PAGE followed by immuno-blotting with a rabbit antibody against CDC42 (Santa Cruz, CA, USA).
Immunoblotting
10
6 cells of parental cell lines or each transfectant were suspended in 200 ml of SDS sample buer and boiled for 15 min. Proteins in each sample were separated by 12% SDS ± PAGE, and transferred onto polyvinylidene di¯uoride membrane (Millipore) and immunoblotting was carried out according to the procedure described previously (Wang et al., 1997) using antibodies against Ha-Ras (Oncogene Science) or CDC42 (Santa Cruz).
Construction of the plasmid that expresses the CDC42 binding domain of ACK-1
To express the minimal CDC42 binding domain (residues 504 ± 545, ACK42) of human ACK-1 (Manser et al., 1993; Mott et al., 1999) , a pMV7-derived plasmid called pMAK was constructed as previously described (Wang et al., 1997) . Brie¯y, an EcoRI/HindIII DNA fragment encoding the ACK42 was prepared by polymerase chain reaction (PCR) using a pair of primers (sense, AA GAA TTC GCC GCC ACC ATG GGC CTG TCG GCC CAG GAC A TC; antisense, CC AAG CTT TTA GTT TCC CAG ATA CAG TTC GTC). In this DNA the consensus Kozak sequence is followed by the initiation codon. The DNA was subcloned into the vector pMV7 (Maruta et al., 1991) , and both orientation and nucleotide sequence of the insert were con®rmed by sequencing. The resultant plasmid was purified by CsCl density gradient centrifugation and used for subsequent transfection experiments.
Construction of a plasmid that expresses GST-HA-WR-ACK42 fusion protein
To prepare a gene encoding a GST fusion protein containing a hemagglutinin epitope (HA), a penetratin of 16 amino acids called WR, and ACK42, ®rst a template DNA for HA-WR was generated by an end-®lling reaction using a pair of primers, BHRS (5'-G GAA GGA TCC ATG AAG AAC GGA AAC ATG CGG GCT ACT ATT GCA ATA AGA AGA-3') and RHA (5'-TCT TCT CCA CCA TCT TCT CCA CCA TCT TCT CCA TCT TCT TAT TGC AAT AG-3'). Second, a DNA encoding AKC42 was generated by PCR using a pair of primers, WAS (5'-AGA TGG TGG AGA AGA TGG AGA AGA GGC CTG TCG GCC CAG-3') and EAA (5'-TT GAA TTC CTA GTT TCC CAG ATA CAG T-3'). The template DNAs from end-®lling and PCR reactions were separated by agarose gel electrophoresis (AGE) followed by puri®cation using`Sephaglass Band Prep Kit' (Pharmacia) according to the manufacturer's instruction. These two DNA pieces were ligated and ampli®ed by PCR using the primers BHRS and EAA. The PCR product was digested with BamHI and EcoRI, and subcloned into the BamHI/EcoRI sites of the vector pGEX-2TH (Maruta et al., 1991) . The insert was con®rmed by nucleotide sequencing.
Anity-puri®cation of GST-HA-WR-ACK42 fusion protein and its thrombin cleavage
The GST fusion protein of HA-WR-ACK42 was induced in E. coli by 20 mM of isopropyl-beta-galactopyranoside (IPTG) at 288C for 7 h, and anity-puri®ed as described previously (Maruta et al., 1991) . The cell-permeable ACK42 derivative, HA-WR-ACK42, was then separated from GST by thrombin (Sigma Chemicals)-cleavage according to the manufacturer's instruction.
Assay for pharmacological eect of the cell-permeable ACK42 derivative 2610 5 v-Ha-Ras transformed NIH3T3 cells were seeded in 2 ml of the culture medium RPMI containing 1% fetal calf serum (FCS), and incubated overnight as described previously (Maruta et al., 1991) . The thrombin-digested GST-HA-WR-ACK42 (or GST and thrombin alone as a control) at various concentrations was added to the culture, and cells were further incubated for another 48 h. Cells were then trypsinized and counted in a hemocytometer.
Expression of ACK42 in v-Ha-Ras transformed NIH3T3 cells v-Ha-Ras-transformed NIH3T3 cells (Maruta et al., 1991) , which are sensitive to neomycin, were cultured to 60% con¯uency in RPMI medium containing 10% FCS under the standard culture conditions. The cells were then transfected with either the plasmid pMAK or the vector pMV7 alone, 2 mg each as complexes with 20 ml of transfectin (GIBCO ± BRL), as described previously (Nur-E-Kamal et al., 1992) . The transfected cells were allowed to grow in the presence of 400 mg/ml G418 (a neomycin analog). After 18 days, neomycin resistant transfected colonies (clones) were isolated under microscope, and each of these clones was cultured separately for further analysis.
Soft agar colony (SAC) formation assay 10 3 cells of either the parental v-Ha-Ras transformants, the vector alone or pMAK (ACK42) transfectants were inoculated per plate in soft agar as described previously (Maruta et al., 1991) in tetraplicate. The cells were incubated for 20 days under standard culture conditions. After staining, the number of colonies were determined under microscope.
Determination of contact inhibition and serum requirement v-Ha-Ras transformed 3T3 cells and their clones derived by transfection with either the pMAK or the vector alone were cultured in RPMI containing 10% FCS, and G418 (stable transfectants only). To investigate the contact inhibition (or saturation density) of growth, the same number of cells were seeded, and at various intervals cells were trypsinized and counted in a hemocytometer. To study their serum requirement, the same number of cells were inoculated in the medium containing either 0.5 or 10% FCS. At various intervals cells were trypsinized and counted. Each experiment was performed in triplicate and the average values are shown.
Northern blotting
Poly(A)
+ RNA was isolated from parental cells as well as from the stable transfectants as described previously (Nur-EKamal et al., 1992) . Two mg of poly(A) + RNA from each cell line was applied to 1.2% agarose gel electrophoresis (AGE) to separate poly(A) + RNAs. Poly(A) + RNAs from the gel were transferred onto nylon membrane and probed with a radiolabeled ACK24 cDNA. Membranes were washed as described previously (Nur-E-Kamal et al., 1992) and scanned by phosphoimager (Bio Rad Model, Molecular Imager System GS-525).
Immunostaining of HA-WR-ACK42 treated cells
Fibroblasts were cultured in RPMI medium containing 1% FCS in the presence or absence of HA-WR-ACK42 (2.5 mg/ ml) for 2 h. The cells were ®xed with 3.7% formaldehyde in phosphate buered saline (PBS) for 20 min. They were then treated with 0.5% Triton X-100 in PBS for 5 min, and washed three times in PBS. Cells were treated with rabbit antibodies against HA tag. The samples were then treated with TRITC conjugated anti-rabbit IgG antibodies (Sigma Chemicals). After mounting the coverslip with immuno¯uor mounting medium (ICN), cells were analysed under ā uorescent microscope (Zeiss Axivert 405M).
Eect of ACK42 on ®lopodium/microspike formation
Ras-transformants were cultured on coverslips under the standard conditions, until reaching around 60% con¯uency. The wounds were made by scraping cells through the middle of coverslips with sterile yellow tips (Nobes and Hall, 1999) . Cells were then cultured in a fresh RPMI (plus 0.5% FCS) containing HA-WR-ACK42 (3 mg/ml) or GST alone as the control for 6 h, until 25% of the gap was ®lled. Cells were ®xed with 2% paraformaldehyde, permeabilized with 1% Triton X-100 in PBS, and stained with TRITC-conjugated phalloidin (Sigma Chemicals). Cells were then visualized under¯uorescent light and images were taken using a confocal microscope (Axiovert 100 TV, Zeiss LSM).
Abbreviations ACK42, CDC42-binding fragment of ACK-1; AGE, agarose gel electrophoresis; BB2R, bradykinin B2 receptor, FCS, fetal calf serum; GAP, GTPase activating protein; GDSs, GDP-dissociation stimulators; GST, glutathione S-transferase; IPTG, isopropyl-beta-galactopyranoside; NGF, nerve growth factor; NOG, neurite outgrowth; PAGE, polyacrylamide gel electrophoresis; PCR, polymerase chain reaction; SDS, sodium dodecylsulphate; WR-ACK42, cell-permeable ACK42 derivative.
